Both FibroQ and FIB-4 include elements such as age, AST, PLT, and ALT, which have been identified as risk factors for unfavorable outcomes in cerebrovascular diseases (Wang et al., 2021, 2022; Li et al., 2022; Eto et al., 2024), aligning with our results. This evidence concerns the gene GPT and cerebrovascular disorder.